Related Experiment Video
Updated: Nov 29, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Heart Failure in Diabetes Mellitus: An Updated Review
Catrin Sohrabi1, Bunny Saberwal2, Wei-Yao Lim2
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Insights
Diabetes mellitus and heart failure remain serious global health issues. This review examines glucose-lowering drugs
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus (DM) and heart failure (HF) are prevalent comorbidities
- These conditions contribute significantly to global morbidity and mortality rates.
- Despite advancements, high mortality and hospitalization persist.
Purpose of the Study:
- To review the impact of glucose-lowering therapies on heart failure outcomes in patients with diabetes.
- To explore non-conventional management strategies for DM and HF.
- To discuss potential therapeutic targets based on alternative pathophysiological mechanisms.
Main Methods:
- Literature review of current glucose-lowering therapies.
- Analysis of clinical outcomes related to heart failure.
- Exploration of emerging pathophysiological insights.
Main Results:
- Certain glucose-lowering therapies demonstrate varying effects on heart failure outcomes.
- Intensive glycemic control alone has not fully mitigated HF risks.
- Novel therapeutic pathways are under investigation.
Conclusions:
- The choice of glucose-lowering therapy is critical for managing heart failure in diabetic patients.
- Further research into novel mechanisms and treatments is warranted.
- Integrated management strategies are essential for improving patient outcomes.
Abstract:
Diabetes mellitus (DM) and heart failure (HF) are comorbid conditions associated with significant morbidity and mortality worldwide. Despite the availability of novel and effective therapeutic options and intensive glycaemic control strategies, mortality and hospitalisation rates continue to remain high and the incidence of HF persists. In this review, we described the impact of currently available glucose-lowering therapies in DM with a focus on HF clinical outcomes. Non-conventional modes of management and alternative pathophysiological mechanisms with the potential for therapeutic targeting are also discussed.
More Related Videos
Related Concept Videos
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions

